This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Novaliq Gmbh, Phenex Pharmaceuticals Ag. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Inventor Thomas Schlüter: Innovations in Ophthalmic Treatments
Introduction
Thomas Schlüter, an inventive mind located in Heidelberg, Germany, has made significant contributions to the field of ophthalmology. With an impressive portfolio of four patents, Schlüter focuses on developing innovative treatments for ocular conditions, particularly dry eye disease.
Latest Patents
Schlüter's latest inventions showcase his dedication to improving eye care. His first significant patent details an ophthalmic composition for the treatment of dry eye disease, which includes about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane. This invention not only provides effective topical treatment methods but also encompasses kits containing the formulated compositions.
Another noteworthy patent involves ophthalmic compositions comprising semifluorinated alkanes aimed at treating keratoconjunctivitis sicca and Meibomian gland dysfunction. This technology emphasizes methods for enriching ophthalmic tissue with the semifluorinated alkane, as well as providing strategies for a delayed release of the compound, enhancing its efficacy in treatment.
Career Highlights
Over the years, Thomas Schlüter has collaborated with esteemed companies such as Novaliq GmbH and Phenex Pharmaceuticals AG. His work within these organizations has fueled advancements in ophthalmic therapies, positioning him as a knowledgeable figure in the pharmaceutical landscape.
Collaborations
Throughout his career, Schlüter has exchanged ideas and knowledge with skilled professionals, including notable coworkers Sonja Krösser and Chiara Silvana Leo. Their combined efforts contribute to the growth and innovation within the ophthalmology sector, allowing for a collaborative approach to developing new treatments.
Conclusion
Thomas Schlüter is a remarkable inventor whose insights and inventions continue to advance the field of eye care. His patents emphasize the importance of innovative solutions to common ocular conditions, showcasing his expertise and commitment to improving patient outcomes. With a career marked by groundbreaking work and meaningful collaborations, Schlüter stands at the forefront of ophthalmic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile